Literature DB >> 15228096

Heat-inactivated C. pneumoniae organisms are not atherogenic.

Jyotika Sharma1, Yuhong Niu, Jianbo Ge, Grant N Pierce, Guangming Zhong.   

Abstract

We have previously shown that infection with Chlamydia pneumoniae can significantly exacerbate atherosclerotic lesions in LDLR-/- mice concurrently fed a high cholesterol diet in 6 or 9 months. We now report that a period of 4 month was sufficient for demonstrating the C. pneumoniae atherogenicity. However, heat inactivation of C. pneumoniae organisms completely abolished the ability of C. pneumoniae to exacerbate the atherosclerotic lesions, suggesting that viable organism infection may be required for the C. pneumoniae atherogenicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228096     DOI: 10.1023/b:mcbi.0000026066.64125.71

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.

Authors:  J B Muhlestein
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

4.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  T C Moazed; L A Campbell; M E Rosenfeld; J T Grayston; C C Kuo
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

5.  Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice.

Authors:  E Blessing; L A Campbell; M E Rosenfeld; N Chough; C C Kuo
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

6.  Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.

Authors:  Mihai G Netea; Bart Jan Kullberg; Jochem M D Galama; Anton F H Stalenhoef; Charles A Dinarello; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

7.  Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells.

Authors:  M V Kalayoglu; B N Perkins; G I Byrne
Journal:  Microbes Infect       Date:  2001-10       Impact factor: 2.700

8.  Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.

Authors:  Victor E A Gerdes; Roel P Verkooyen; Vincent I H Kwa; Eric de Groot; Eric C M van Gorp; Hugo ten Cate; Dees P M Brandjes; Harry R Büller
Journal:  Atherosclerosis       Date:  2003-03       Impact factor: 5.162

9.  Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure.

Authors:  Bernadette Donath; Claudia Fischer; Sharon Page; Sigrid Prebeck; Nikolaus Jilg; Marion Weber; Clarissa da Costa; Dieter Neumeier; Thomas Miethke; Korbinian Brand
Journal:  Atherosclerosis       Date:  2002-11       Impact factor: 5.162

10.  Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease.

Authors:  Olaimatu S Mahdi; Benjamin D Horne; Kelly Mullen; Joseph B Muhlestein; Gerald I Byrne
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

View more
  6 in total

1.  Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells.

Authors:  Feng Dong; Rhonda Flores; Ding Chen; Jianhua Luo; Youmin Zhong; Zhongming Wu; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

2.  Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane.

Authors:  Jianhua Luo; Tianjun Jia; Rhonda Flores; Ding Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

3.  Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.

Authors:  Feng Dong; Youmin Zhong; Bernard Arulanandam; Guangming Zhong
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol.

Authors:  Xiang Wu; Lei Lei; Siqi Gong; Ding Chen; Rhonda Flores; Guangming Zhong
Journal:  BMC Microbiol       Date:  2011-04-28       Impact factor: 3.605

5.  Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.

Authors:  Shankar J Evani; Shatha F Dallo; Anand K Ramasubramanian
Journal:  Front Microbiol       Date:  2016-08-17       Impact factor: 5.640

6.  TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Authors:  Yoshikazu Naiki; Rosalinda Sorrentino; Michelle H Wong; Kathrin S Michelsen; Kenichi Shimada; Shuang Chen; Atilla Yilmaz; Anatoly Slepenkin; Nicolas W J Schröder; Timothy R Crother; Yonca Bulut; Terence M Doherty; Michelle Bradley; Zory Shaposhnik; Ellena M Peterson; Peter Tontonoz; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.